Vanguard Discloses Position in Spire Healthcare

The Vanguard Group, Inc. has filed a Form 8.3 regarding its interests in Spire Healthcare Group plc, underlining its stakes in the healthcare provider. On November 3, 2025, Vanguard held 14,425,128 ordinary shares, representing 3.58% of Spire. This positions Vanguard as a significant stakeholder as defined under Rule 8.3 of the Takeover Code.

The disclosure reveals minor transactions, including a purchase of 1,176 shares and a sale of 4,632 shares, both at a price of 2.33 GBP per share. Vanguard has not been involved in cash or stock-settled derivative transactions related to Spire. Furthermore, no additional securities subscriptions or agreements were reported.

There are no indemnity arrangements or voting agreements in place related to Spire’s securities. Vanguard's disclosure follows regulatory requirements, aiming for transparency in its securities dealings.